To print this article, all you need is to be registered or login on Mondaq.com.
The Food and Drug Administration has taken many steps to assist
in the response to the COVID-19 health crisis, including easing
regulations, expediting the availability of necessary medical
equipment, and creating streamlined procedures for developing tests
and potential treatments. In addition to its advice to
industry and business, FDA recently issued an infographic and
consumer update designed for the general public regarding how
everyone can help during the COVID-19 pandemic. Because the
"
Make a Difference" infographic and update provides simple,
FDA-approved recommendations and links to trusted resources for
additional information, employers and businesses may find it
helpful to share with workers, customers, and/or the
public. Both the infographic and the consumer update are
also available in
Spanish and
Chinese to reach broader audiences.
The Department of Health & Human Services' Office of Inspector General (HHS OIG) and U.S. Department of Justice (DOJ) have published important guidance and recommendations for pharmaceutical...
In August 2023, we published a blog post about the California Office of Health Care Access and Information's ("OHCA") proposed cost and market impact review ("CMIR") regulations under the California Health Care Quality and Affordability Act ("Proposed Regulations").
You only get to incorporate once, and you want to get it right. In this episode, co-hosts Halle Tecco and Michael Esquivel dive deep into the process of incorporation for startups.
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape.
In this two-part Triage series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton discuss an old health care regulatory doctrine that has new relevance in a post-COVID world, where the delivery of care via telemedicine...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.